The ABC’s of Antibody Drug Conjugate (ADC)

Date & Time

Mar 6th at 1:00 PM until 2:30 PM



Rating ( votes)

The development of antibody drug conjugates (ADCs) represents a novel approach to improving the therapeutic index of cytotoxic agents by selectively delivering potent cytotoxic drugs to tumors while minimizing exposure and toxicity to normal tissues. Although there are several ADCs in clinical development, the roadmap for the development of ADC's is not well defined. The goal of this symposium is to provide an overview of advances in clinical pharmacology, PK/PD and regultoary understanding for characterization of ADCs.